Evidence map›Paper›PMID 27028368›Full record

ArticleObesity (Silver Spring, Md.)2016

Zinc delays the progression of obesity-related glomerulopathy in mice via down-regulating P38 MAPK-mediated inflammation.

Manyu Luo, Ping Luo, Zhiguo Zhang, Kristen Payne, Sara Watson, Hao Wu, Yi Tan, Yushuang Ding, Weixia Sun, Xinmin Yin and 5 more

Open access · greenAbstract read
In one paragraph

Article in Obesity (Silver Spring, Md.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Renoprotection by Inhibiting Connexin 43 Expression in a Mouse Model of Obesity-Related Renal Injury.Diabetes, metabolic syndrome and obesity : targets and therapy · 2023
    Article
  10. Article
  11. FGF1Biochimica et biophysica acta. Molecular basis of disease · 2022
    Article
  12. Article
  13. Obesity-Related Glomerulopathy: From Mechanism to Therapeutic Target.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Manyu LuoDepartment of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Ping LuoDepartment of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Zhiguo ZhangDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Kristen PayneDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Sara WatsonDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Hao WuDepartment of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Yi TanDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Yushuang DingDepartment of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Weixia SunDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Xinmin YinDepartment of Chemistry, The University of Louisville, Kentucky, USA.
Xiang ZhangDepartment of Chemistry, The University of Louisville, Kentucky, USA.
Gilbert LiuDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Kupper WintergerstDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
Lining MiaoDepartment of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin, China.
Lu CaiDepartment of Pediatrics, The University of Louisville, Kentucky, USA.
University of Louisville · USSecond Affiliated Hospital of Jilin University · CNJilin University · CNMarshall University · US

Funding

Metabolomics study on the preventive mechanisms for LDR on diabetic nephropathyR01DK091338 · NIDDK · UNIVERSITY OF LOUISVILLE · PI CAI, LU · 2013 to 2014
$900k
NIDDK NIH HHS R01 DK091338
6 · The paper itself

Abstract

objectiveObesity, particularly child obesity, is one of the most common public health problems in the world and raises the risk of end-stage renal disease. Zinc (Zn) is essential for multiple organs in terms of normal structure and function; however, effects of Zn deficiency or supplementation among young individuals with obesity have not been well studied.

methodsWeaned mice were fed high-fat diets (HFD) with varied contents of Zn (Zn deficient, adequate, and supplemented) for 3 or 6 months. This study examined associations between renal pathogenesis and dietary Zn levels, specifically assessing inflammatory pathways by utilizing P38 MAPK inhibitor SB203580.

resultsHFD feeding induced typical syndromes of obesity-related renal disorders, which worsened by Zn marginal deficiency. The progression of obesity-related renal disorders was delayed by Zn supplementation. HFD induced renal inflammation, reflected by increased P38 MAPK phosphorylation along with increases of inflammatory cytokines MCP-1, IL-1β, IL-6, and TNF-α. P38 MAPK inhibition prevented renal pathological changes in mice fed with HFD and HFD/Zn deficiency.

conclusionsP38 MAPK mediated the renal inflammatory responses, which played a central role in the pathogenesis of HFD-induced renal disorders. Zn could delay the progression of obesity-related kidney disease by down-regulating P38 MAPK-mediated inflammation.

Indexed as

AnimalsCytokinesDeficiency DiseasesDiet, High-FatDisease Models, AnimalInflammationInflammation MediatorsKidney DiseasesMiceMice, Inbred C57BLObesityp38 Mitogen-Activated Protein KinasesZincCytokinesInflammation Mediatorsp38 Mitogen-Activated Protein KinasesZinc

Identifiers

PMID27028368
PMCPMC7218660
OpenAlexW2321215493

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.